Mapping off-label use and reimbursement pathways for oncology drugs in The Netherlands: a cross-sectional observational study.
- DOI
- 10.1016/j.esmoop.2026.108609
- Published
- 2026 Oct 30
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2026.108609,
title = {Mapping off-label use and reimbursement pathways for oncology drugs in The Netherlands: a cross-sectional observational study.},
author = {Timmer H and Huisman AH and Gelderblom H and Barjesteh van Waalwijk van Doorn-Khosrovani S},
year = {2026},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2026.108609},
url = {https://doi.org/10.1016/j.esmoop.2026.108609}
}RIS
TY - JOUR TI - Mapping off-label use and reimbursement pathways for oncology drugs in The Netherlands: a cross-sectional observational study. AU - Timmer H AU - Huisman AH AU - Gelderblom H AU - Barjesteh van Waalwijk van Doorn-Khosrovani S PY - 2026 JO - ESMO open DO - 10.1016/j.esmoop.2026.108609 UR - https://doi.org/10.1016/j.esmoop.2026.108609 ER -
APA
H, T., AH, H., H, G., & S, B. V. W. V. D. (2026). Mapping off-label use and reimbursement pathways for oncology drugs in The Netherlands: a cross-sectional observational study.. ESMO open. https://doi.org/10.1016/j.esmoop.2026.108609
Source records
- pubmed · retrieved 2026-11-10T11:29:43.927Z